The Global Cruciate Ligament Diagnosis & Treatment Market is projected to reach USD 9.2 Billion by 2030 at 9.40% CAGR during the forecast period 2022-2030.

Global Cruciate Ligament Diagnosis And Treatment Market Overview:

Ligaments are bands of tissue that hold the bones together and keep the knee stable. Mainly, these ligaments are broadly classified as cruciate ligaments and collateral ligaments. It is also divided into four major ligaments: anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), medial collateral ligament (MCL), and lateral collateral ligament (LCL). The cruciate ligaments, or PCL and ACL, are cross ligaments that allow a very wide range of motion while stabilizing the joint. Knee injuries are the most common musculoskeletal trauma among people in general, and anterior cruciate ligament (ACL) injuries are among the most frequent knee injuries. Surgical reconstruction is the gold standard treatment for knee injuries. The increasing incidence of sports-related injuries has become a leading cause of soft tissue injuries worldwide. Athletes are most likely to injure their ACLs, preventing them from fully straightening their legs. One type of surgery to reconstruct the ligaments is known as ACL reconstruction, in which a graft is placed in the middle of the knee. According to an article published in PubMed (2017), an average of about 200,000 ACL injuries are registered each year in the United States. After that, it is most commonly treated in athletes because sports-related activities are mostly affected by ACL injuries.

Various factors such as an increase in the number of knee reconstruction surgeries, an aging population, an increase in the incidence of age-related diseases such as rheumatoid arthritis and osteoarthritis, and increased government support continue to contribute to the growth of the cruciate ligament diagnosis and treatment market. .

Despite these drivers, there are several challenges associated with the cruciate ligament diagnosis and treatment market. Treatment-related complications, lack of skilled or trained doctors, and poor healthcare systems in low- and middle-income countries may hamper the growth of the market.

Cruciate Ligament Diagnosis And Treatment market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Cruciate Ligament Diagnosis And Treatment market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Major Market Segments Covered in Cruciate Ligament Diagnosis And Treatment Market Research:

Market Key Players:
Stryker, Arthrex, Zimmer Biomet, DePuy Synthes, Conmed, Smith & Nephew, And Others.

By Type:

• Posterior Cruciate Ligament (PCL)
• Anterior Cruciate Ligament (ACL)
• Other

By Application:

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Center (ASC)
• Other

By Product:

• Cemented implants
• Cement-less implants
• Partial implants
• Revision implants
• Other

By Region:

The Americas dominate the cruciate ligament diagnosis and treatment market due to the increasing prevalence of osteoarthritis among the geriatric population, well-developed surgical techniques, high healthcare expenditure, and presence of major players.

This market is attracting many key players such as Stryker Corporation. Zimmer Biomet; DePuySynthes, Inc., Arthrex, Inc.; Smith & Nephew plc; and COMED Corporation. For example, Smith & Nephew acquired a diverse portfolio of products for orthopedic soft tissue treatment from ArthroCare Corporation, further strengthening the company's presence in the global market.

Europe ranks second in the cruciate ligament diagnosis and treatment market. Increasing contributions to research and development for surgical implant development and intensifying competition among marketers for drug launches are expected to lead the European cruciate ligament diagnosis and treatment market. For example, in May 2017, Ablynx, a Belgian-based biopharmaceutical company, announced that it had completed the preclinical package of ALX-1141, a novel nanobody for the treatment of osteoarthritis. Merck will now be responsible for further clinical development of the molecule.

Asia Pacific is the fastest-growing cruciate ligament diagnosis and treatment market owing to huge patient pool, growing demand for treatment, and rising healthcare expenditure. For example, in July 2017, Kolon Pharmaceutical received domestic approval for the world's first cell and gene therapy for knee osteoarthritis. Thus, all these factors are cumulatively responsible for the growth of this region.

The Middle East and Africa account for the lowest share of the global cruciate ligament diagnosis and treatment market due to underdevelopment, lack of technical knowledge and poor medical facilities.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Cruciate Ligament Diagnosis And Treatment Market Report Scope:

Crucial Points from this Cruciate Ligament Diagnosis And Treatment Market Report

• Estimate Cruciate Ligament Diagnosis And Treatment market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the Cruciate Ligament Diagnosis And Treatment market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

What is the CAGR of Cruciate Ligament Diagnosis And Treatment market?

The Cruciate Ligament Diagnosis And Treatment Market is growing at a CAGR of 9.4% During Forecast Period.

 What are the key types of Cruciate Ligament Diagnosis And Treatment market?

Posterior Cruciate Ligament (PCL), Anterior Cruciate Ligament (ACL)

What are the key applications of Cruciate Ligament Diagnosis And Treatment market?

Hospitals, Orthopedic Clinics, Ambulatory Surgical Center (ASC)    

Who are the key players in Cruciate Ligament Diagnosis And Treatment market?

Stryker, Arthrex, Zimmer Biomet, DePuy Synthes, Conmed, Smith & Nephew, and others.